The future of the global bioanalytical testing services market looks promising with opportunities in the oncology, neurology, infectious diseases, gastroenterology, and cardiology markets. The global bioanalytical testing services market is expected to reach an estimated $9.4 billion by 2030 with a CAGR of 15.2% from 2024 to 2030. The major drivers for this market are increasing emphasis towards the development of advanced bioanalytical technologies for enhanced testing and growing trend of outsourcing laboratory testing services.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the bioanalytical testing
services market by type (cell-based assays, bacterial cell-based assays, viral
cell-based assays, virology testing, in vitro virology testing, in vivo
virology testing, species-specific viral PCR assays, method development,
optimization, and validation, and others), application (oncology, neurology,
infectious diseases, gastroenterology, and cardiology), end use (pharmaceutical
and biopharmaceutical companies, contract development and manufacturing
organizations, and contract research organizations), and region (North America,
Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
cell-based assays, bacterial cell-based assays, viral cell-based assays,
virology testing, in vitro virology testing, in vivo virology testing,
species-specific viral PCR assays, method development, optimization, and validation
are the major segments of bioanalytical testing services market by type.
Lucintel forecasts that cell-based assays will remain the largest segment over
the forecast period due to high occurence of chronic diseases and the
increasing number of clinical trials.Within this market, oncology will remain
the largest segment due to growing number of clinical trials conducted for
cancer.
APAC is expected to
witness highest growth over the forecast period due to growing emphasis on
developing new drugs for the treatment of various diseases.
Charles River, Medpace,
WuXi AppTec, Eurofins Scientific, IQVIA, SGA SA, Laboratory Corporation,
Intertek, Syneos Health, and ICON are the major suppliers in the bioanalytical
testing services market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Explore Our Latest Publications
Homecare Oxygen Concentrator
Market
Non-Volatile Memory
(NCM) Market
Coworking Space
Mangement Software Market
Gamma-Aminobutyric
Acid (GABA) Market
No comments:
Post a Comment